With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Mechanisms of LYL1-associated T-ALL development||Baylor College of Medicine / Margaret Goodell, PhD||Innovation Grants||2012||Texas|
|Novel STAT3 drug development for childhood osteosarcoma therapy using drug repositioning||Research Institute at Nationwide Children's Hospital / Jiayuh Lin, PhD||Innovation Grants||2012||Ohio|
|Developing Immune-modulatory Strategies Against Primary and Metastatic Tumors in the Central Nervous System||Case Western Reserve University / Alex Huang, MD, PhD||Innovation Grants||2012||Ohio|
|Searching for genetic vulnerabilities in osteosarcoma through genome-wide RNAi screening||Dana-Farber Cancer Institute / Stuart Orkin, MD||Innovation Grants||2012||Massachusetts|
|The role of vitamin D in hepatoblastoma formation and prevention||Brigham and Women's Hospital / Wolfram Goessling, MD/PhD||Innovation Grants||2012||Massachusetts|
|Development of the Next Generation FLT3 Inhibitors for Pediatric AML and Infant ALL||The Johns Hopkins University School of Medicine / Donald Small, MD, PhD||Innovation Grants||2012||Maryland|
|Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing sarcoma||Dana-Farber Cancer Institute / Kimberly Stegmaier, MD||Bridge Grants||2012||Massachusetts|
|Discovery of New Targets and Pathways for T-ALL Therapy||Dana-Farber Cancer Institute / Thomas Look||Bridge Grants||2012||Massachusetts|
|The role of NOTCH1 in T-cell acute lymphoblastic leukemia.||Columbia University Medical Center / Adolfo Ferrando||Bridge Grants||2012||New York|